Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 6, 2011, Pages 775-785

  Cohn, Susan E ^a,b   Jiang, Hongyu ^c   McCutchan, J Allen ^d   Koletar, Susan L ^e   Murphy, Robert L ^b   Robertson, Kevin R ^f   De St Maurice, Annabelle M ^g   Currier, Judith S ^h   Williams, Paige L ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UCLA MEDICAL CENTER   (United States)

Author keywords

adherence; alcohol use; antiretroviral therapy; drug use; HIV AIDS; mortality; outcomes; substance use

Indexed keywords

AMPHETAMINE; ANTIRETROVIRUS AGENT; COCAINE; DIAMORPHINE; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; DEATH; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; TREATMENT REFUSAL;

ADULT; ALCOHOL-RELATED DISORDERS; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; RNA, VIRAL; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 79956323731     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.525617     Document Type: Article

References (44)

1. Arnsten, J.H., Demas, P.A., Grant, R.W., Gourevitch, M.N., Farzadegan, H., Howard, A.A., & Schoenbaum, E.E. (2002). Impact ofactive drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377-381. (Pubitemid 34626108)
2. Bassetti, S., Battegay, M., Furrer, H., Rickenbach, M., Flepp, M., Kaiser, L.,... Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 21(2), 114-119. (Pubitemid 29250074)
3. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S.,... Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721-728. (Pubitemid 32717795)
4. Braithwaite, R.S., McGinnis, K.A., Conigliaro, J., Maisto, S.A., Crystal, S., Day, N.,... Justice, A.C. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism: Clinical and Experimental Research, 29(7), 1190-1197. (Pubitemid 41060434)
5. Carrico, A.W., Johnson, M.O., Morin, S.F., Remien, R.H., Riley, E.D., Hecht, F.M., & Fuchs, D. (2008). Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain, Behavior, and Immunity, 22, 1257-1262.
6. CDC. (2006, June 2). Epidemiology ofHIV/AIDS - United States 1981-2005. MMWR, 55(21), 589-592. Retrieved from
7. Chander, G., Himelhoch, S., & Moore, R.D. (2006). Substance abuse and psychiatric disorders in HIVpositive patients: Epidemiology and impact on antiretroviral therapy. Drugs, 66(6), 769-789. (Pubitemid 43765224)
8. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., & Wu, A.W. (2000). Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group ofthe Outcomes Committee ofthe Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266. (Pubitemid 30426745)
9. Cofrancesco, J., Jr., Scherzer, R., Tien, P.C., Gibert, C.L., Southwell, H., Sidney, S.,... Grunfeld, C. (2008). Illicit drug use and HIV treatment outcomes in a US cohort. AIDS, 22(3), 357-365.
10. Cohn, S.E., Kammann, E., Williams, P., Currier, J.S., & Chesney, M.A. (2002). Association ofadherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clinical Infectious Diseases, 34(8), 1129-1136. (Pubitemid 34289687)
11. Cohn, S.E., Umbleja, T., Mrus, J., Bardequez, A.D., Andersen, J., & Chesney, M.A. (2008). Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy. AIDS Patient Care and STDs, 22, 29-40.
12. Conen, A., Fehr, J., Glass, T.R., Furrer, H., Weber, R., Vernazza, P.,... Battegay, M. (2009). Self-reported alcohol consumption and its association with adherence and outcome ofantiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14(3), 349-357.
13. Currier, J.S., Williams, P.L., Koletar, S.L., Cohn, S.E., Murphy, R.L., Heald, A.E.,... McCutchan, J.A. (2000). Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy- induced increases in CD4- cell count. Annals of Internal Medicine, 133, 493-503.
14. Dhillon, N.K., Williams, R., Peng, F., Tsai, Y.J., Dhillon, S., Nicolay, B.,... Buch, S.J. (2007). Cocaine-mediated enhancement ofvirus replication in macrophages: Implications for human immunodeficiency virus-associated dementia. Journal for Neurovirology, 13(6), 483-495.
15. Elliott, M.K., Sisson, J.H., & Wyatt, T.A. (2007). Effects of cigarette smoke and alcohol on ciliated tracheal epithelium and inflammatory cell recruitment. American Journal of Respiratory Cell and Molecular Biology, 36(4), 452-459. (Pubitemid 46623003)
16. Gebo, K.A., Fleishman, J.A., Conviser, R., Reilly, E.D., Korthuis, P.T., Moore, R.D.,... Mathews, W.C. (2005). Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample ofHIV patients in 2001. Journal of Acquired Immune Deficiency Syndromes, 38(1), 96-103. (Pubitemid 40094126)
17. Golin, C.E., Liu, H., Hays, R.D., Miller, L.G., Beck, C.K., Ickovics, J.,... Wenger, N.S. (2002). A prospective study ofpredictors ofadherence to combination antiretroviral medication. Journal of General Internal Medicine, 17(10), 756-765. (Pubitemid 35286241)
18. Hajjeh, R.A., Conn, L.A., Stephens, D.S., Baughman, W., Hamill, R., Graviss, E.,... Pinner, R.W. (1999). Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. The Journal of Infectious Diseases, 179(2), 449-454. (Pubitemid 29086648)
19. Haubrich, R.H., Little, S.J., Currier, J.S., Forthal, D.N., Kemper, C.A., Beall, G.N.,... McCutchan, J.A. (1999). The value ofpatient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13(9), 1099-1107. (Pubitemid 29361401)
20. Kapadia, F., Cook, J.A., Cohen, M.H., Sohler, N., Kovacs, A., Greenblatt, R.M.,... Vlahov, D. (2005). The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort ofHIV seropositive women in the era ofhighly active antiretroviral therapy use. Addiction, 100(7), 990-1002. (Pubitemid 40897294)
21. Kohli, R., Lo, Y., Howard, A.A., Buono, D., Floris- Moore, M., Klein, R.S., & Schoenbaum, E.E. (2005). Mortality in an urban cohort ofHIV-inf ected and atrisk drug users in the era ofhighly active antiretroviral therapy. Clinical Infectious Diseases, 41(6), 864-872. (Pubitemid 41266755)
22. Koletar, S.L., Williams, P.L., Wu, J., McCutchan, J.A., Cohn, S.E., Murphy, R.L.,... Currier, J.S. (2004). Long-term follow-up of HIV-infected individuals who have significant increases in CD4- cell counts during antiretroviral therapy. Clinical Infectious Diseases, 39(10), 1500-1506. (Pubitemid 39518215)
23. Leitch, G.J., Frid, L.H., & Phoenix, D. (1985). The effects ofethanol on mucociliary clearance. Alcoholism: Clinical and Experimental Research, 9, 277-280.
24. Lucas, G.M., Cheever, L.W., Chaisson, R.E., & Moore, R.D. (2001). Detrimental effects of continued illicit drug use on the treatment ofHIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27(3), 251-259. (Pubitemid 32661966)
25. Lucas, G.M., Gebo, K.A., Chaisson, R.E., & Moore, R.D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16(5), 767-774. (Pubitemid 34274467)
26. Lucas, G.M., Griswold, M., Gebo, K.A., Keruly, J., Chaisson, R.E., & Moore, R.D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era ofhighly active antiretroviral therapy. American Journal of Epidemiology, 163(5), 412-420.
27. Lyles, C.M., Margolick, J.B., Astemborski, J., Graham, N.M., Anthony, J.C., Hoover, D.R., & Vlahov, D. (1997). The influence ofdrug use patterns on the rate ofCD4 - lymphocyte decline among HIV-1-infected injecting drug users. AIDS, 11(10), 1255-1262. (Pubitemid 27298092)
28. Mientjes, G.H., Miedema, F., van Ameijden, E.J., van den Hoek, A.A., Schellekens, P.T., Roos, M.T., & Coutinho, R.A. (1991). Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS, 5(1), 35-41.
29. Mocroft, A., Madge, S., Johnson, A.M., Lazzarin, A., Clumeck, N., Goebel, F.D.,... Lundgren, J.D. (1999). A comparison ofexposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival. Journal of Acquired Immune Deficiency Syndromes, 22(4), 369-378. (Pubitemid 30030429)
30. Moore, R.D., Keruly, J.C., & Chaisson, R.E. (2004). Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. Journal of Acquired Immune Deficiency Syndromes, 35(1), 46-51. (Pubitemid 38044781)
31. National Institute on Alcohol Abuse and Alcoholism. (2005). Helping patients who drink too much. A Clinician's Guide. Washington, DC: U.S. Department ofHealth and Human Services, National Institutes of Health.
32. Palella, F.J., Jr., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A.,... Holmberg, S.D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England Journal of Medicine, 338(13), 853-860. (Pubitemid 28135961)
33. Palepu, A., Tyndall, M., Yip, B., O'Shaughnessy, M.V., Hogg, R.S., & Montaner, J.S. (2003). Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. Journal of Acquired Immune Deficiency Syndromes, 32(5), 522-526. (Pubitemid 36423124)
34. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C.,... Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30. (Pubitemid 30432540)
35. Peterson, P.K., Sharp, B.M., Gekker, G., Portoghese, P.S., Sannerud, K., & Balfour, H.H., Jr., (1990). Morphine promotes the growth ofHIV-1 in human peripheral blood mononuclear cell cocultures. AIDS, 4(9), 869-873. (Pubitemid 20342117)
36. Roth, M.D., Whittaker, K.M., Choi, R., Tashkin, D.P., & Baldwin, G.C. (2005). Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. Journal of Leukocyte Biology, 78(6), 1198-1203. (Pubitemid 41779224)
37. Spijkerman, I.J., Langendam, M.W., Veugelers, P.J., van Ameijden, E.J., Keet, I.P., Geskus, R.B.,... Coutinho, R.A. (1996). Differences in progression to AIDS between injection drug users and homosexual men with documented dates ofseroconversion. Epidemiology, 7(6), 571-577. (Pubitemid 26353449)
38. Tishler, C.L., Bartholomae, S., & Rhodes, A.R. (2005). Personality profiles ofnormal healthy research volunteers: A potential concern for clinical drug trial investigators? Medical Hypotheses, 65(1), 1-7. (Pubitemid 40704520)
39. Turner, B.J., Fleishman, J.A., Wenger, N., London, A.S., Burnam, M.A., Shapiro, M.F.,... Bozzette, S.A. (2001). Effects of drug abuse and mental disorders on use and type ofantiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16(9), 625-633. (Pubitemid 32823894)
40. Tucker, J.S., Burnam, M.A., Sherbourne, C.D., Kung, F.Y., & Gifford, A.L. (2003). Substance use and mental health correlates ofnonadherence to antiretroviral medications in a sample ofpatients with human immunodeficiency virus infection. American Journal of Medicine, 114(7), 573-580. (Pubitemid 36577260)
41. Walley, A.Y., Cheng, D.M., Libman, H., Nunes, D., Horsburgh, C.R. Jr, Saitz, R., & Samet, J.H. (2008). Recent drug use, homelessness and increased shortterm mortality in HIV-infected persons with alcohol problems. AIDS, 22(3), 415-420.
42. Weber, R., Huber, M., Rickenbach, M., Furrer, H., Elzi, L., Hirschel, B.,... Ledergerber, B. (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV Cohort Study. HIV Medicine, 10, 407-416.
43. Wood, E., Montaner, J.S., Yip, B., Tyndall, M.W., Schechter, M.T., O'Shaughnessy, M.V., & Hogg, R.S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ, 169(7), 656-661. (Pubitemid 37266973)
44. Wright, D., Sathe, N., & Spagnola, K. (2007). State estimates of substance use from the 2004-2005 national surveys on drug use and health (DHHS Publication No. SMA 07-4235, NSDUH Series H-31). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Retrieved from